These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 16829624)
1. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2. Walraven JM; Doll MA; Hein DW J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624 [TBL] [Abstract][Full Text] [Related]
2. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens. Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359 [TBL] [Abstract][Full Text] [Related]
3. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847 [TBL] [Abstract][Full Text] [Related]
4. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse. Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913 [TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184 [TBL] [Abstract][Full Text] [Related]
6. Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes. Leggett CS; Doll MA; States JC; Hein DW Arch Toxicol; 2021 Jan; 95(1):311-319. PubMed ID: 33136180 [TBL] [Abstract][Full Text] [Related]
7. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Grant DM; Blum M; Beer M; Meyer UA Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083 [TBL] [Abstract][Full Text] [Related]
8. Recombinant rat and hamster N-acetyltransferases-1 and -2: relative rates of N-acetylation of arylamines and N,O-acyltransfer with arylhydroxamic acids. Jones RF; Land SJ; King CM Carcinogenesis; 1996 Aug; 17(8):1729-33. PubMed ID: 8761433 [TBL] [Abstract][Full Text] [Related]
9. Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the rat. Barker DF; Walraven JM; Ristagno EH; Doll MA; States JC; Hein DW Drug Metab Dispos; 2008 Dec; 36(12):2445-51. PubMed ID: 18799802 [TBL] [Abstract][Full Text] [Related]
10. Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation. Hein DW; Zhang X; Doll MA Toxicol Lett; 2018 Feb; 283():100-105. PubMed ID: 29180287 [TBL] [Abstract][Full Text] [Related]
11. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats. Jefferson FA; Xiao GH; Hein DW Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621 [TBL] [Abstract][Full Text] [Related]
12. Human Hein DW; Doll MA; Habil MR Front Pharmacol; 2022; 13():821133. PubMed ID: 35281898 [TBL] [Abstract][Full Text] [Related]
13. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines. Liu L; Wagner CR; Hanna PE Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618 [TBL] [Abstract][Full Text] [Related]
14. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding. Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241 [TBL] [Abstract][Full Text] [Related]
15. Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli. Dupret JM; Goodfellow GH; Janezic SA; Grant DM J Biol Chem; 1994 Oct; 269(43):26830-5. PubMed ID: 7929420 [TBL] [Abstract][Full Text] [Related]
16. Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster. Hein DW; Doll MA; Xiao GH; Feng Y Pharmacogenetics; 2003 Mar; 13(3):159-67. PubMed ID: 12618593 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Evidence for multiplicity of N-acetyltransferases in the intestine. Ware JA; Svensson CK Biochem Pharmacol; 1996 Nov; 52(10):1613-20. PubMed ID: 8937477 [TBL] [Abstract][Full Text] [Related]
18. Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2. Fakis G; Boukouvala S; Buckle V; Payton M; Denning C; Sim E Cytogenet Cell Genet; 2000; 90(1-2):134-8. PubMed ID: 11060463 [TBL] [Abstract][Full Text] [Related]
19. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2. Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512 [TBL] [Abstract][Full Text] [Related]
20. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens. Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]